Last reviewed · How we verify
NCT03510975
A New Check-list Method for Nocturnal Enuresis
Phase 4 trial testing desmopressin melt form 120 μg in Nocturnal Enuresis in 75 participants. Completed in 1 March 2018.
31 December 2017
Quick facts
| Lead sponsor | Ankara Training and Research Hospital |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 75 |
| Start date | 1 January 2015 |
| Primary completion | 31 December 2017 |
| Estimated completion | 1 March 2018 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- desmopressin melt form 120 μg — full drug profile →
- Verbal behavioral therapy
- Behavioral therapy with written check-list
Conditions studied
- Nocturnal Enuresis — all drugs for Nocturnal Enuresis →
Sponsor
Ankara Training and Research Hospital
Who can join
Adults 6 to 15, any sex, with Nocturnal Enuresis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is aimed to demonstrate the benefits of newly formed written check-list of behavioral instructions and investigate its effects on parent's awareness, consciousness and motivation toward MNE. The parents with children who complain of bed-wetting 3 or more nights per week for at last 14 days, they was randomly divided into three groups. The parents in Group I were instructed only a verbal behavioral therapy, the parents in Group II were instructed a behavioral therapy with a written formed check-list for parents to fulfill and the children in Group III will received desmopressin treatment plus verbal behavioral therapy. All participants were analysed the compliance and response rate of treatment over time period of 8 week.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03510975
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of desmopressin melt form 120 μg
Trials testing the same drug.
- NCT07028645 — Uroflowmetry and Nocturnal Enuresis · active not recruiting
Other recruiting trials for Nocturnal Enuresis
Currently open trials in the same condition.
- NCT06285006 — Desmopressin Monotherapy for Monosymptomatic Nocturnal Enuresis · NA · recruiting
- NCT06135311 — Optimal Pulse Width Used in Transcutaneous Electrical Nerve Stimulation for Treating Nocturnal Enuresis in Children · NA · recruiting
Other Ankara Training and Research Hospital trials
Trials by the same sponsor.
- NCT07150455 — Evaluation of Myocardial Function by Global Longitudinal Strain (GLS) Measurement in 2D Echocardiography of Patients Wit · completed
- NCT07467421 — "Effectiveness of Physical Therapy Added to Transforaminal Injection in Lumbar Radicular Pain" · NA · completed
- NCT07143084 — Investigation of the Relationship Between Nutritional Status Assessment and Frailty in Critical Care Patients · enrolling by invitation
- NCT07310667 — Assessing the Relationship Between Frailty and Skeletal Muscle Thickness in Critically Ill Patients · enrolling by invitation
- NCT06946030 — Pseudoexfoliation and Carpal Tunnel Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03510975 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara Training and Research Hospital
- Last refreshed: 1 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03510975.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing